Impax Laboratories (IPXL) Launches Generic Metadate CD

September 22, 2016 8:04 AM EDT

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Impax Laboratories, Inc. (Nasdaq: IPXL) announced the launch of a generic version of Metadate CD (methylphenidate hydrochloride extended-release capsules), 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg.

Impax is focused on further enhancing its portfolio of 73 solid oral dose and alternative dosage form generic products available. The launch of methylphenidate hydrochloride is Impax's sixth new product launch since the beginning of 2016.

Methylphenidate hydrochloride extended-release capsules had annual combined brand and generic sales of approximately $151 million in the United States, according to IMS Health (NSP) for the 12 months ending in July 2016.

For full Prescribing Information see

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News

Add Your Comment